Acceptability and Preference for 3-Month Versus 1-Month Vaginal Rings for HIV-1 Risk Reduction Among Participants in a Phase 1 Trial

BACKGROUND: The monthly dapivirine vaginal ring provides partial protection against HIV, and a longer duration ring may reduce user burden and improve adherence. We examined acceptability and preference for 3-month versus 1-month rings for HIV-1 risk reduction in a phase 1 clinical trial. MATERIALS...

Descripción completa

Detalles Bibliográficos
Autores principales: Roberts, Sarah T., Hawley, Imogen, Luecke, Ellen, Mensch, Barbara, Wagner, Theresa, Hoesley, Craig, McClure, Tara, Dominguez Islas, Clara P., Piper, Jeanna M., Liu, Albert Y., van der Straten, Ariane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299526/
https://www.ncbi.nlm.nih.gov/pubmed/34665672
http://dx.doi.org/10.1089/jwh.2021.0121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299526/
https://www.ncbi.nlm.nih.gov/pubmed/34665672
http://dx.doi.org/10.1089/jwh.2021.0121

Ejemplares similares